Table 3.

Hospital healthcare use

Hospital healthcare use, n (%) Exposed vs. unexposed Odds ratio (95% CI)		Pre-intervention		Intervention		Intervention add-on
		Exposed N = 652	Unexposed N = 17.248	Exposed N = 540	Unexposed N = 15.734	Exposed N = 326	Unexposed N = 9.385
Surgery Last 30 days of life	n (%)	56 (9%)	1.993 (12%)	46 (9%)	1.537 (10%)	23 (7%)	727 (8%)
	Crude	0.72 (0.55–0.96)		0.86 (0.63–1.17)		0.90 (0.59–1.39)
	Adjusted*	0.78 (0.59–1.04)		0.94 (0.69–1.28)		0.87 (0.56–1.35)
Radiological examinations Last 30 days of life	n (%)	248 (38%)	6.554 (38%)	200 (37%)	6.451 (41%)	147 (45%)	3.848 (41%)
	Crude	1.02 (0.87–1.20)		0.87 (0.73–1.04)		1.17 (0.93–1.46)
	Adjusted*	1.17 (0.99–1.38)		0.94 (0.78–1.13)		1.21 (0.96–1.52)
Antineoplastic treatment Last 14 days of life	n (%)	17 (3%)	581 (3%)	13 (2%)	439 (3%)	10 (3%)	200 (2%)
	Crude	0.77 (0.47–1.26)		0.86 (0.49–1.50)		1.45 (0.76–2.77)
	Adjusted*	0.90 (0.55–1.49)		1.06 (0.60–1.88)		1.60 (0.83–3.11)

Exposed: Patients exposed to PalMaGiC—palliative care case management for gastrointestinal cancer. Unexposed: patients with gastrointestinal cancer in standard care

*Crude and Adjusted logistic regression analysis adjusted for age, gender, diagnosis, Charlson Comorbidity Index, education level, cohabitation status, and admission to specialized palliative care